Field Trip Health, Another Psychedelic Therapy Company, Goes Public

  • 📰 Forbes
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 53%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Field Trip, which runs ketamine infusion clinics in Canada and the U.S., is developing a novel psychedelic molecule in hopes to make a brand-new pharmaceutical drug.

for suicidal ideation and treatment-resistant depression last year, but Field Trip sells intramuscular ketamine injections in the U.S., which produces a more intense psychedelic experience.

The third strategy Field Trip is pursuing is psilocybin cultivation. It partnered with the University of the West Indies in Mona, Jamaica, where psilocybin is legal, to build a magic mushroom research and cultivation facility. Field Trip was founded by Levy, Joseph del Moral, Hannan Fleiman, Ryan Yermus and Mujeeb Jafferi in April 2019. All of the cofounders except for Jafferi worked together previously in Canada’s cannabis industry, where they cofounded medical marijuana companies Canadian Cannabis Clinics and CanvasRx, the later of which was acquired by Aurora Cannabis for $37 million in 2016.

Nearly 30% of people with major depression don’t respond to current medications, says Weinand. A drug that could help this patient population could be “quite significant,” he says.

 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 394. in KR

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

How Figma CEO Dylan Field grew the $2 billion design software startup - Business InsiderThe demand for user experience and product design in tech are growing, and apps like Instagram, Uber, Slack, TikTok, and even Starbucks have become popular largely because of their design. In partnership with ING_news ING_news
출처: BusinessInsider - 🏆 729. / 51 더 많은 것을 읽으십시오 »